Talk:Fremanezumab
Appearance
This is the talk page for discussing improvements to the Fremanezumab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Fremanezumab.
|
Image
[edit]The image should be that of the molecule rather than a syringe. — Preceding unsigned comment added by Tommycarstensen (talk • contribs) 07:07, 7 August 2020 (UTC)
- An X-ray structure of the molecule would be nice, but I doubt there is one available. A structural formula is out of the question – the molecule has over 6000 carbon atoms... --ἀνυπόδητος (talk) 07:57, 7 August 2020 (UTC)
Is cluster headache a type of migraine
[edit]migraine and cluster headache say they are distinct, but the sources and Teva seem to overlap them; & see the phase 3 trial names. - Rod57 (talk) 12:43, 30 November 2017 (UTC)
- They're different. Triptans (and apparently fremanezumab) are effective against both. --ἀνυπόδητος (talk) 13:21, 30 November 2017 (UTC)
- Thanks. I also found [1] which says "Lithium is beneficial in cluster headache but would exacerbate migraine." Sadly many headlines say migraine when the text talks about cluster headaches. - Rod57 (talk) 21:30, 30 November 2017 (UTC)